$0.3940
0.03389.38%
Last update: Nov 9, 7:58 PM
Tenaya Therapeutics Inc
TNYANASDAQ
Tenaya Therapeutics fell 72.4% from $1.43 to $0.39, behind the S&P 500's +10.5%. Its worst day was Dec 12 (−37.5%), and its low came Nov 5 at $0.32.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.12 beat the $-0.15 estimate on $0.00 revenue.
0.0% · S&P 500 +1.6%
Tenaya Therapeutics shares fell 37.5%, while the S&P 500 fell 1.1%.
Story events cover the past 12 months · Times ET
−37.5%, the year's worst day, on 67M shares, the year's heaviest volume · S&P 500 −1.1%
Tenaya Therapeutics shares rose 19.7%, while the S&P 500 fell 0.2%.
+19.7% · S&P 500 −0.2%
EPS of $-0.12 beat the $-0.12 estimate on $0.00 revenue.
+4.0% · S&P 500 −1.5%
EPS of $-0.09 beat the $-0.09 estimate on $25.0M revenue (est. $8.0M).
+7.4% · S&P 500 −0.3%
EPS of $-0.20 missed the $-0.07 estimate on $1.1M revenue (est. $10.0M).
−7.5% · S&P 500 −0.2%
Tenaya Therapeutics shares fell 25.0%, while the S&P 500 fell 1.1%.
−25.0% · S&P 500 −1.1%
EPS of $-0.08 beat the $-0.10 estimate on $1.7M revenue (est. $850,000.00).
−14.6% · S&P 500 −4.4%
Where it ended: a close of $0.39 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 10, 2027 (EPS est. $-0.09, revenue est. $1.6M).
Nothing in the past 12 months.
All TNYA dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TNYA and SPY from Benzinga historical bars. Not investment advice.
